| Literature DB >> 31860641 |
Marinda Henskens1, Ilse M Nauta2, Susan Vrijkotte3, Katja T Drost4, Maarten V Milders1, Erik J A Scherder1.
Abstract
OBJECTIVES: To examine the predictors associated with quality of life of nursing home residents with dementia, in order to identify which predictors are most important and hold most promise for future intervention studies. METHODS/Entities:
Mesh:
Year: 2019 PMID: 31860641 PMCID: PMC6924675 DOI: 10.1371/journal.pone.0223704
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Descriptive statistics for demographic and clinical predictors (N = 143).
| Variables | Participants |
|---|---|
| 85.65 (6.09) | |
| 111 (77.60) | |
| Alzheimer’s disease (AD) | 62 (43.40) |
| Vascular dementia (VD) | 19 (13.30) |
| Mixed AD and VD | 12 (8.40) |
| Dementia not otherwise specified | 47 (32.90) |
| Korsakoff | 2 (1.40) |
| Unknown | 1 (0.60) |
| 11.10 (5.45) | |
| 48.78 (14.57) | |
| 26.83 (7.94) | |
| 8.07 (4.62) | |
| Care relationship | 14.74 (4.10) |
| Positive affect | 14.68 (3.30) |
| Negative affect | 5.69 (2.30) |
| Restless tense behavior | 4.59 (2.48) |
| Positive self-image | 6.43 (2.18) |
| Social relations | 12.24 (3.94) |
| Social isolation | 6.19 (2.04) |
| Feeling at home | 8.92 (2.60) |
| Having something to do | 2.85 (1.92) |
| 76.31 (15.22) | |
| 2.62 (1.32) | |
| 3.36 (1.86) | |
| Endocrine/metabolic disease | 44 (30.80) |
| Heart/cardiovascular disease | 105 (73.40) |
| Diseases of musculoskeletal system | 50 (35.00) |
| Neurological diseases | 35 (24.50) |
| Sensory impairment | 52 (36.40) |
| Psychiatric/mood disorders | 19 (13.30) |
| Pulmonary | 13 (9.10) |
| Other | 57 (39.90) |
a Diabetes mellitus, hypothyroidism, hyperthyroidism;
b Arteriosclerotic disease, arrhythmias, heart failure, deep vein thrombosis, hypertension, hypotension, peripheral vascular disease, other;
c Rheumatic diseases, hip fracture, amputation, osteoporosis, pathologic bone fracture;
d Aphasia, cerebral palsy, stroke, hemiplegia/hemiparesis, paraplegia, multiple sclerosis, Parkinson disease, seizures, transient cerebral ischemia, traumatic brain injury, quadriplegia;
e Cataract, diabetic retinopathy, glaucoma, macular degeneration;
f Anxiety disorder, depression, manic depression, schizophrenia;
g Asthma, emphysema/COPD;
h Allergies, anemia, cancer, renal failure
Abbreviations. MMSE, mini-mental state examination; QoL, quality of life; CMAI, Cohen-Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; AES-10, apathy evaluation scale-10.
Results of the simple linear mixed regression analyses with Qualidem as dependent variable.
| Care relationship | Positive affect | Negative affect | Restless tense behavior | Positive self-image | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | |
| 0.06 (-0.05, 0.17) | 0.09 | 0.11 (0.02, 0.20) | 0.20 | 0.03 (-0.04, 0.09) | 0.08 | 0.05 (-0.02, 0.12) | 0.12 | -0.02 (-0.08, 0.04) | -0.06 | |
| 0.52 (-1.10, 2.13) | 0.05 | 0.71 (-0.59, 2.01) | 0.09 | -0.81 (-1.71, 0.10) | -0.15 | 0.08 (-0.91, 1.07) | 0.01 | -0.69 (-1.55, 0.17) | -0.13 | |
| -0.06 (-0.18, 0.07) | -0.08 | 0.14 (0.05, 0.24) | 0.23 | 0.06 (-0.01, 0.13) | 0.14 | 0.08 (0.00, 0.15) | 0.18 | 0.05 (-0.01, 0.12) | 0.13 | |
| -0.10 (-0.14, -0.06) | -0.36 | -0.08 (-0.12, -0.05) | -0.35 | -0.05 (-0.07, -0.02) | -0.32 | -0.11 (-0.13, -0.08) | -0.65 | -0.04 (-0.07, -0.02) | -0.27 | |
| 0.02 (-0.07, 0.10) | 0.04 | -0.22 (-0.28, -0.17) | -0.53 | -0.01 (-0.06, 0.04) | -0.03 | -0.03 (-0.08, 0.03) | -0.10 | -0.06 (-0.10, -0.01) | -0.22 | |
| -0.29 (-0.43, -0.15) | -0.33 | -0.34 (-0.44, -0.23) | -0.48 | -0.28 (-0.35, -0.21) | -0.56 | -0.23 (-0.31, -0.15) | -0.43 | -0.17 (-0.24, -0.10) | -0.36 | |
| 0.78 (-0.67, 2.24) | 0.09 | 0.21 (-0.97, 1.39) | 0.03 | 0.36 (-0.47, 1.18) | 0.07 | 0.88 (0.00, 1.76) | 0.16 | 0.30 (-0.48, 1.08) | 0.06 | |
| Cardiovascular diseases | -0.64 (-2.16, 0.89) | -0.07 | -0.16 (-1.40, 1.07) | -0.02 | 0.22 (-0.65, 1.08) | 0.04 | 0.16 (-0.77, 1.10) | 0.03 | 0.21 (-0.61, 1.03) | 0.04 |
| Musculoskeletal disorder | -0.45 (-1.86, 0.97) | -0.05 | 0.27 (-0.88, 1.41) | 0.04 | -0.53 (-1.33, 0.27) | -0.11 | 0.13 (-0.73, 0.99) | -0.03 | -0.48 (-1.24, 0.27) | -0.11 |
| -2.17 (-3.69, -0.64) | -0.23 | -1.52 (-2.8, -0.28) | -0.20 | 0.00 (-0.89, 0.89) | 0.00 | -0.75 (-1.70, 0.20) | -0.12 | 0.06 (-0.78, 0.90) | 0.01 | |
| Sensory impairment | 0.06 (-1.36, 1.47) | 0.01 | 0.16 (-0.98, 1.31) | 0.02 | -0.14 (-0.93, 0.65) | -0.03 | -0.60 (-1.45, 0.25) | -0.12 | -0.41 (-1.16, 0.34) | -0.09 |
| -0.30 (-2.28, 1.68) | -0.03 | -0.99 (-2.59, 0.61) | -0.10 | -0.43 (-1.55, 0.70) | -0.06 | -0.63 (-1.83, 0.58) | -0.09 | -1.21 (-2.26, -0.17) | -0.19 | |
| 0.56 (-1.79, 2.91) | 0.04 | 0.30 (-1.60, 2.19) | 0.03 | 0.26 (-1.07, 1.59) | 0.03 | 1.38 (-0.04, 2.79) | 0.16 | 0.28 (-0.98, 1.54) | 0.04 | |
| -0.80 (-2.18, 0.57) | -0.10 | -0.31 (-1.43, 0.81) | -0.05 | 0.76 (-0.01, 1.53) | 0.16 | 0.56 (-0.28, 1.39) | 0.11 | 0.22 (-0.52, 0.95) | 0.05 | |
| Total comorbidities | -0.22 (-0.59, 0.14) | -0.10 | -0.11 (-0.40, 0.19) | -0.06 | 0.11 (-0.10, 0.31) | 0.09 | -0.02 (-0.24, 0.20) | -0.02 | -0.07 (-0.27, 0.12) | -0.06 |
| 3.75 (0.88, 6.61) | 0.21 | 1.85 (-.51, 4.20) | 0.13 | -.06 (-1.73, 1.60) | -0.01 | 0.30 (-1.49, 2.09) | 0.03 | 0.12 (-1.45, 1.70) | 0.01 | |
Qualidem: higher (sub)scores indicate higher QoL; Bold values represent predictor variables to be entered in the final multiple linear regression analyses (p-values < 0.10).
Abbreviations: MMSE, mini-mental state examination; CMAI, Cohen-Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; AES-10, apathy evaluation scale-10; B, unstandardized regression coefficient; β, standardized regression coefficient.
**p < .005
* p < .05,
Results of the simple linear mixed regression analyses with Qualidem as dependent variable.
| Social relations | Social isolation | Feeling at home | Having something to do | Total QoL | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | B (95%CI) | β | |
| 0.04 (-0.06, 0.15) | 0.06 | 0.01 (-0.05, 0.06) | 0.03 | 0.04 (-0.03, 0.11) | 0.09 | -0.02 (-0.07, 0.03) | -0.06 | 0.29 (-0.11, 0.69) | 0.12 | |
| 1.65 (0.18, 3.12) | 0.18 | 0.76 (-0.02, 1.54) | 0.16 | -0.42 (-1.45, 0.61) | -0.07 | -0.03 (-0.74, 0.68) | 0.01 | 1.86 (-3.99, 7.71) | 0.05 | |
| 0.22 (0.10, 0.33) | 0.30 | 0.05 (-0.01, 0.12) | 0.13 | -0.04 (-0.12, 0.04) | -0.08 | 0.11 (0.05, 0.16) | 0.31 | 0.61 (0.15, 1.07) | 0.22 | |
| -0.02 (-0.07, 0.02) | -0.07 | -0.05 (-0.07, -0.03) | -0.36 | -0.06 (-0.09, -0.03) | -0.34 | 0.01 (-0.02, 0.03) | 0.08 | -0.50 (-0.65, -0.36) | -0.48 | |
| -0.27 (-0.34, -0.21) | -0.54 | -0.03 (-0.07, 0.01) | -0.12 | 0.01 (-0.05, 0.06) | 0.03 | -0.15 (-0.18, -0.12) | -0.62 | -0.75 (-1.04, -0.46) | -0.39 | |
| -0.18 (-0.32, -0.05) | -0.21 | -0.14 (-0.21, -0.07) | -0.32 | -0.13 (-0.23, -0.04) | -0.23 | -0.05 (-0.11, 0.02) | -0.12 | -1.78 (-2.23, -1.33) | -0.54 | |
| 0.13 (-1.22, 1.47) | 0.02 | 0.31 (-0.40, 1.02) | 0.07 | 0.43 (-0.50, 1.37) | 0.08 | 0.11 (-0.54, 0.75) | 0.03 | 3.13 (-2.13, 8.40) | 0.10 | |
| Cardiovascular diseases | 0.09 (-1.33, 1.50) | 0.01 | 0.50 (-0.24, 1.25) | 0.11 | 0.39 (-0.59, 1.36) | 0.07 | -0.22 (-0.90, 0.45) | 0.05 | 0.50 (-5.05, 6.05) | 0.02 |
| Musculoskeletal disorder | 0.51 (-0.80, 1.82) | 0.06 | 0.35 (-0.34, 1.04) | 0.08 | -0.51 (-1.41, 0.39) | -0.09 | -0.28 (-0.90, 0.35) | -0.07 | -1.22 (-6.36, 3.91) | -0.04 |
| -1.65 (-3.08, 0.22) | -0.18 | -1.07 (-1.83, -0.31) | -0.23 | -0.45 (-1.46, 0.56) | -0.07 | -0.34 (-1.04, 0.36) | -0.08 | -7.71 (-13.34, -2.08) | -0.22 | |
| Sensory impairment | 0.30 (-1.03, 1.63) | 0.04 | 0.40 (-0.30, 1.10) | 0.10 | -0.17 (-1.07, 0.73) | -0.03 | 0.13 (-0.51, 0.76) | 0.03 | -0.61 (-5.81, 4.59) | -0.02 |
| -2.86 (-4.62, -1.10) | -0.25 | -0.68 (-1.64, 0.28) | -0.11 | 0.81 (-0.46, 2.07) | 0.11 | -0.21 (-1.07, 0.66) | -0.04 | -6.44 (-13.52, 0.65) | -0.15 | |
| -1.61 (-3.76, 0.55) | -0.12 | 0.32 (-0.82, 1.47) | 0.05 | -0.17 (-1.68, 1.33) | -0.02 | 0.17 (-0.87, 1.20) | 0.03 | 1.31 (-7.20, 9.83) | 0.02 | |
| 0.37 (-1.65, 0.92) | 0.05 | 0.29 (-0.39, 0.97) | 0.07 | 0.35 (-0.53, 1.24) | 0.07 | -0.31 (-0.93, 0.31) | -0.08 | 0.49 (-4.58, 5.56) | 0.02 | |
| Total comorbidities | -0.21 (-0.55, 0.12) | -0.10 | 0.05 (-0.13, 0.23) | 0.05 | 0.04 (-0.20, 0.27) | 0.03 | -0.11 (-0.27, 0.05) | -0.11 | -0.57 (-1.89, 0.74) | -0.07 |
| 3.43 (0.79, 6.08) | 0.20 | 1.11 (-0.32, 2.54) | 0.13 | -1.39 (-3.25, 0.47) | -0.12 | 0.78 (-0.50, 2.06) | 0.09 | 10.32 (-0.18, 20.8) | 0.16 | |
Qualidem: higher (sub)scores indicate higher QoL; Bold values represent predictor variables to be entered in the final multiple linear regression analyses (p-values < 0.10).
Abbreviations: MMSE, mini-mental state examination; CMAI, Cohen-Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; AES-10, apathy evaluation scale-10; B, unstandardized regression coefficient; β, standardized regression coefficient.
**p < .005
* p < .05,
Multiple linear mixed regression analysis of associations between Qualidem scales and predictors (n = 143).
| B (95%CI) | β | ||||
|---|---|---|---|---|---|
| 0.21 | |||||
| Agitation (CMAI) | -0.07 (-0.12, -0.03) | -0.25 | 0.003 | ||
| Neurological diseases | -1.87 (-3.29, -0.44) | -0.20 | 0.01 | ||
| Depression (CSDD) | -0.16 (-0.31, -0.01) | -0.18 | 0.04 | ||
| 0.43 | |||||
| Apathy (AES-10) | -0.19 (-0.24, -0.13) | -0.46 | <0.001 | ||
| Depression (CSDD) | -0.20 (-0.31, -0.10) | -0.28 | <0.001 | ||
| Agitation (CMAI) | -0.04 (-0.07, -0.01) | -0.18 | 0.02 | ||
| 0.36 | |||||
| Depression (CSDD) | -0.27 (-0.34, -0.20) | -0.56 | <0.001 | ||
| 0.43 | |||||
| Agitation (CMAI) | -0.09 (-0.11, -0.06) | -0.53 | <0.001 | ||
| Depression (CSDD) | -0.10 (-0.18, -0.02) | -0.19 | 0.01 | ||
| Endocrine/metabolic | 0.74 (0.07, 1.42) | 0.14 | 0.03 | ||
| Pulmonary | 1.19 (0.11, 2.28) | 0.14 | 0.03 | ||
| 0.14 | |||||
| Depression (CSDD) | -0.17 (-0.24, -0.10) | -0.36 | <0.001 | ||
| 0.47 | |||||
| Apathy (AES-10) | -0.26 (-0.32, -0.19) | -0.52 | <0.001 | ||
| Psychiatric disorder | -2.17 (-3.61, -0.73) | -0.19 | 0.003 | ||
| Male gender | 1.87 (0.71, 3.03) | 0.20 | 0.002 | ||
| No comorbidities vs >1 | 2.69 (0.57, 4.80) | 0.16 | 0.01 | ||
| 0.25 | |||||
| Agitation (CMAI) | -0.05 (-0.07, -0.03) | -0.36 | 0.001 | ||
| Neurological diseases | -1.05 (-1.74, -0.35) | -0.22 | 0.004 | ||
| 0.10 | |||||
| Agitation (CMAI) | -0.06 (-0.09, -0.03) | -0.34 | <0.001 | ||
| 0.52 | |||||
| Apathy (AES-10) | -0.15 (-0.18, -0.12) | -0.62 | <0.001 | ||
| 0.50 | |||||
| Depression (CSDD) | -1.11 (-1.57, -0.66) | -0.33 | <0.001 | ||
| Agitation (CMAI) | -0.31 (-0.45, -0.17) | -0.30 | <0.001 | ||
| Apathy (AES-10) | -0.49 (-0.73, -0.25) | -0.26 | <0.001 | ||
| Neurological diseases | -5.53 (-9.76, -1.30) | -0.15 | 0.01 | ||
Qualidem: higher (sub)scores indicate higher QoL; Outcome variables: care relationship, positive affect, negative affect, restless tense behavior, positive self-image, social relations, social isolation, feeling at home, having something to do, total QoL; Predictor variables: agitation, apathy, depression, neurological disease, endocrine/metabolic disease, pulmonary disease, psychiatric disorder, no comorbidities vs >1 comorbidity, male gender.
Abbreviations. B, unstandardized regression coefficient; β, standardized regression coefficient; CMAI, Cohen-Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; AES-10, apathy evaluation scale-10; QoL, quality of life.